Tetrahydroamentoflavone

CAS No. 48236-96-0

Tetrahydroamentoflavone ( —— )

Catalog No. M29347 CAS No. 48236-96-0

Tetrahydroamentoflavone is a potent XO inhibitor (IC50 = 92 nM, Ki = 982 nM) with anti-inflammatory effects. Tetrahydroamentoflavone can be used for studies about inflammation and gout.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tetrahydroamentoflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    Tetrahydroamentoflavone is a potent XO inhibitor (IC50 = 92 nM, Ki = 982 nM) with anti-inflammatory effects. Tetrahydroamentoflavone can be used for studies about inflammation and gout.
  • Description
    Tetrahydroamentoflavone is a potent XO inhibitor (IC50 = 92 nM, Ki = 982 nM) with anti-inflammatory effects. Tetrahydroamentoflavone can be used for studies about inflammation and gout.(In Vitro):Tetrahydroamentoflavone shows in vitro cyclooxygenase (COX) inhibition activity with an IC50 of 29.5 microM for COX-1 and 40.5% inhibition at 100 microg/mL for COX-2.
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    48236-96-0
  • Formula Weight
    542.5
  • Molecular Formula
    C30H22O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O)cc(O)c(c2O1)-c1cc(ccc1O)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Polmacoxib

    Polmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II.

  • Sulindac

    Sulindac is a nonsteroidal anti-inflammatory agent (NSAIA) of the arylalkanoic acid class that is marketed in the U.S. by Merck as Clinoril.

  • Mavacoxib

    Mavacoxib is a selective inhibitor of cyclooxygenase-2 (COX-2) with?Anti-Tumour activity.